Company / EPS (Diluted)
IRADIMED CORP EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.50
FY2025
5-year range
$0.74 / $1.50
FY2021-FY2025
Trend
+11.1%
vs FY2024
Sector context
#63 of 159
Health Care
What the data says
At $1.50, IRADIMED CORP's eps (diluted) ranks #63 of 159 in the Health Care sector. EPS (Diluted) has increased for 3 consecutive years, from $0.74 in FY2022 to $1.50 in FY2025.
Based on SEC 10-K filings.
1.50 in FY2025 with a 5-year CAGR of +23.6%.
Improved from $1.02 to $1.50 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +26.6%
- 5-Year CAGR
- +23.6%
- 10-Year CAGR
- -
Sector benchmark
#63 of 159 in Health CareTop 40% of 159This company $1.50 Sector average $1.67
▼
-10.1% below sector average
Key checks
Key Insights
- IRADIMED CORP's eps (diluted) has grown for 3 consecutive years.
- In FY2025, eps (diluted) increased 11.1% year-over-year.
- Ranks #63 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.50 | +11.1% |
| FY2024 | $1.35 | +32.4% |
| FY2023 | $1.02 | +37.8% |
| FY2022 | $0.74 | -5.1% |
| FY2021 | $0.78 | +50.0% |
| FY2020 | $0.52 | +1200.0% |
| FY2019 | $0.04 | -93.3% |
| FY2018 | $0.60 | +0.0% |
| FY2017 | $0.60 | +200.0% |
| FY2016 | $0.20 | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026